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We use a path integral representation to solve the Eigen and Crow-Kimura molecular evolution
models for the case of multiple fitness peaks with arbitrary fitness and degradation functions. In
the general case, we find that the solution to these molecular evolution models can be written as the
optimum of a fitness function, with constraints enforced by Lagrange multipliers and with a term
accounting for the entropy of the spreading population in sequence space. The results for the Eigen
model are applied to consider virus or cancer proliferation under the control of drugs or the immune
system.
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I. INTRODUCTION
It is widely accepted that biological evolution proceeds
on a rugged fitness landscape [1, 2]. In the last decade,
several exact results [3, 4, 5] have been derived for the
molecular evolution models of Eigen [6, 7] and Crow-
Kimura [8] and their generalizations [9].
In this paper, we consider a multiple-peak replication
rate landscape as a means to model a rugged fitness
landscape. To date, there are few rigorous results for
multiple-peak fitness landscapes. Such results begin to
make the connection with the biologically-relevant case of
a rugged fitness landscape. We here derive error thresh-
olds by means of a path integral representation for both
the Eigen and Crow-Kimura mutation-selection schemes
with an arbitrary number of replication rate peaks.
We first generalize the Crow-Kimura model to the
multiple-peak case. The solution of the single-peak ver-
sion of this model, where the replication rate is a function
of the Hamming distance from one configuration, was
provided by a path integral representation in [4, 5, 10].
We here provide the solution to this model for K peaks,
where the replication rate is a function of the Hamming
distances from K configurations, again by means of a
path integral. We find that the mean distances from
the peaks maximize the replication rate, with constraints
provided by Lagrange multipliers, and with an additional
term that represents the entropy of the population in se-
quence space. Explicit solutions to this maximization
task are given for the two-peak case.
We then generalize and solve the continuous-time
Eigen model for K peaks, where the replication and
degradation rates are functions of the Hamming dis-
tances from K configurations, A solution of the discrete-
time, single-peak Eigen model, which in a sense inter-
polates between the Crow-Kimura and continuous-time
Eigen model [11], was provided in [12]. We here solve
the continuous-time Eigen model for K peaks, again by
means of a path integral representation. The mean dis-
tances from the peaks maximize an excess replication rate
with an effective mutation rate, with constraints pro-
vided by Lagrange multipliers, and with an additional
term that represents the entropy of the population in se-
quence space under the effective mutation rate.
The Eigen model was first developed to study viral evo-
lution [6], and we use our solution of the two-peak Eigen
model to consider viral propagation in the presence of
either immune system suppression or an anti-viral drug.
The preferred viral genome exists at one point in genome
space. Conversely, the drug or immune system suppresses
the virus most strongly at some other point in genome
space. These two points in genome space are the two
peaks of the model. The viral growth rate and the sup-
pression rate both decrease with the Hamming distance
away from these two unique points.
The rest of the paper is organized as follows. In Section
2 we describe the generalization of the Crow-Kimura, or
parallel, model to multiple peaks. We provide a solution
of this model for an arbitrary replication rate function
that depends on distances from K peaks. In Section 3,
we describe the Eigen model. We provide a solution for
arbitrary replication and degradation rate functions that
depend on distances from K peaks. In Section 4, we use
the Eigen model theory to address the interaction of the
immune system with a drug. We consider both adaptable
drugs and the original antigenic sin phenomenon [13]. We
also consider tumor suppression by the immune system.
We discuss these results and conclude in section 5. We
provide a derivation of the path integral representation
of the continuous-time Eigen model in the Appendix.
II. CROW-KIMURA MODEL WITH MULTIPLE
PEAKS
Here we first briefly introduce the Crow-Kimura model
[8] and its quantum spin version [3] so that it is eas-
ier to understand its generalizations to be studied in the
present paper. In the Crow-Kimura model, any genotype
configuration i is specified a sequence of N two-valued
spins sn = ±1, 1 ≤ n ≤ N . We denote such configura-
tion i by Si ≡ (si1, . . . , siN ). That is, as in [7], we consider
2sn = +1 to represent the purines (A, G) and sn = −1 to
represent the pyrimidines (C, T). The difference between
two configurations Si and Sj ≡ (sj1, . . . , sjN ) is described
by the Hamming distance dij = (N −
∑
n s
i
ns
j
n)/2, which
is the number of different spins between Si and Sj . The
relative frequency pi of configurations with a given se-
quence 1 ≤ i ≤ 2N satisfies
dpi
dt
= pi(ri −
∑2N
j=1
rjpj) +
∑2N
j=1
µijpj . (1)
Here ri is the the replication rate or the number of
offspring per unit period of time, the fitness, and µij
is the mutation rate to move from sequence Si to se-
quence Sj per unit period of time. In the Crow-Kimura
model, only single base mutations are allowed: µij =
γ∆(dij − 1) − Nγ∆(dij). Here ∆(n) is the Kronecker
delta.
The fitness of an organism with a given genotype is
specified in the Crow-Kimura model by the choice of the
replication rate function ri, which is a function of the
genotype: ri = f(Si). It has been observed [3] that the
system (1), with ri ≡ f(si1, . . . , siN ) evolves according
to a Schro¨dinger equation in imaginary time with the
Hamiltonian:
−H = γ
N∑
n=1
(σxn − 1) + f(σz1 , . . . , σzN ) . (2)
Here σx and σz are the Pauli matrices. The mean
replication rate, or fitness, of the equilibrium popula-
tion of genotypes is calculated as limt→∞
∑
i pi(t)ri =
limβ→∞
1
β lnZ ≡ limβ→∞ 1β lnTr exp(−βH) [7]. In this
way it is possible to find the phase structure and error
threshold of the equilibrium population. In the general-
ized setting, the Crow-Kimura model is often called the
parallel model.
A. The parallel model with two peaks
We consider two peaks to be located at two config-
urations v1n, v
2
n, 1 ≤ n ≤ N , where v1n = ±1, v2n =
±1, and the two configurations have l common spins:∑N
n=1 v
1
nv
2
n = 2l−N . The value of l determines how close
the two peaks are in genotype space. Now the replica-
tion rate of configuration S is a function of the Hamming
distances to each peak:
ri = f(2L1/N − 1, 2L2/N − 1) , (3)
where
∑N
n=1 v
1
nsn = 2L1−N and
∑N
n=1 v
2
nsn = 2L2−N .
Due to the symmetry of the Hamiltonian, the equi-
librium frequencies are a function only of the distances
from the two peaks: pi ≡ p(L1, L2). We define the fac-
tors xα1,α2 that describe the fraction of spins a con-
figuration S has in common with the spins of config-
urations v1, v2. In particular, we define the fraction
of spins that are equal to αk times the value in peak
configuration vk. For K peaks, the general definition
is xα1...αK = (1/N)
∑
n=1,N δ[sn, α1v
1
n] . . . δ[sn, αKv
K
n ].
For the two peak case, these factors are related to the
distances from the configuration to each peak and to the
distance between the peaks:
x+−(L1, L2) = (L1 − L2 +N − l)/(2N)
x++(L1, L2) = (L1 + L2 −N + l)/(2N)
x−−(L1, L2) = (−L1 − L2 +N + l)/(2N)
x−+(L1, L2) = (−L1 + L2 +N − l)/(2N) . (4)
With these factors x, we find the following equation for
the total probability at a given value of L1 and L2,
P (L1, L2):
dP (L1, L2)
dt
= f(
2L1
N
− 1, 2L2
N
− 1)P (L1, L2)
−γNP (L1, L2)
+γ
∑
α1=±1,α2=±1
Nxα1,α2(L1 + α1, L2 + α2)
×P (L1 + α1, L2 + α2)
−P (L1, L2)
N∑
L′1,L
′
2=0
f(
2L′1
N
− 1, 2L
′
2
N
− 1)P (L′1, L′2) .
(5)
Only the values of L1 and L2 satisfying the conditions
0 ≤ Li ≤ N , |L1 + L2 − N | ≤ l, |L1 − L2| ≤ N − l are
associated with non-zero probabilities. Equation (5) can
be solved numerically to find the error threshold and av-
erage distance of the population to the two peaks. In the
next section we solve this equation, and its generalization
to K peaks, analytically.
B. Exact solution of the K peak case by a path
integral representation
We consider the case of K peaks. We consider the
replication rate to depend only on the distances from
each peak
ri = f(
2L1
N
− 1, . . . , 2LK
N
− 1) ≡ Nf0(u1, . . . , uK) , (6)
where Nuk =
∑N
n=1 v
k
nsn = 2Lk − N, 1 ≤ k ≤ K. The
observable value 〈uk〉 is called the surface magnetization
[14], or surplus [3], for peak k.
Characterization of the fitness function that depends
on K peaks through the K values of uk requires more
than the K(K − 1)/2 Hamming distances between the
peaks. It proves convenient to define the 2K parameters
yα1...αK ≡ yi, i ≤ i ≤ 2K . These are defined by yi =
(1/N)
∑N
n=1
∏K
k=1 δ(αik, v
k
n). Here αi is the set of indices
α1 . . . αK , and αik = αk in a i-th set of indices α1 . . . αK .
The introduction of the 2K parameters yi is one principle
point of this article.
3The Trotter-Suzuki method has been applied in [5, 10]
to convert the quantum partition function for a single
peak model into a classical functional integral. While
calculating Z ≡ exp[−βH ], intermediate spin configura-
tions are introduced. We find Z is a functional integral,
with the integrand involving a partition function of a
spin system in 2-d lattice. In the spin system, there is a
nearest-neighbor interaction in horizontal direction and a
mean-field like interaction in the vertical direction. This
spin system partition function was evaluated in [5, 10]
under the assumption that the field values are constant.
A path integral representation of the discrete time Eigen
model, which is quite similar to the parallel model, was
introduced by Peliti [12].
We here generalize this procedure to K peaks and cal-
culate the time-dependent path integral and Ising parti-
tion function. Since the replication rate is a function of
K distances, the functional integral is over K fields that
represent the K magnetizations. The path integral form
of the partition function is
Z =
∫
DMkDHk exp
{
N
∫ β
0
dβ′
[
f0[M1(β
′), . . . ,MK(β
′)]
−
K∑
k=1
Hk(β
′)Mk(β
′)− γ
]
+N
2K∑
i=1
yi lnQ1
}
, (7)
where
Q1 = TrTˆ e
∫
β
0
dβ′
[
σxγ+σz
∑K
k=1
αikHk(β
′)
]
. (8)
Here β = t, is the large time to which Eq. (1) is solved,
and the operator Tˆ denotes time ordering [10], discussed
in the Appendix in the context of the Eigen model. Us-
ing that N is large, we take the saddle point. Consider-
ing δ lnZ/δMk(β
′) = 0 and δ lnZ/δHk(β
′) = 0, we find
Mk(β
′) and Hk(β
′) independent of β′ is a solution. At
long time, therefore, the mean replication rate, or fitness,
per site becomes
lnZ
βN
= max
Mk,Hk
{
f0(M1, . . . ,MK)−
K∑
k=1
HkMk − γ
+
2K∑
i=1
yi
[
γ2 + (
K∑
k=1
αikHk)
2
]1/2 }
. (9)
We take the saddle point in Hk to find
Mk =
∑
i
yiαik
∑K
k′=1 αik′Hk′√
γ2 + (
∑K
k′=1 αik′Hk′)
2
. (10)
We note that the observable, surface, magnetization
given by 〈uk〉 is not directly accessible in the saddle point
limit, but is calculable from the mean replication rate [3].
In the one peak case one defines the observable surface
magnetization for a monotonic fitness function as follows
[15]: one solves the equation f0(〈u〉) = (lnZ)/(βN). For
multiple peaks, we use this same trick, considering a sym-
metric fitness function and assuming 〈u1〉 = 〈u2〉 . . . =
〈uK〉.
C. Explicit results for the two peak case
For clarity, we write the expression for the case of two
peaks. In this case, y++ + y−− = (1 +m)/2 and y+− +
y−+ = (1 − m)/2, where m = (2l − N)/N . We solve
Eq. (10) for the fields Hk and put the result into Eq. (9).
We find that for a pure phase, the bulk magnetizations
maximize the function
lnZ
Nβ
= f0(M1,M2)
+
γ
2
√
(1 +m)2 − (M1 +M2)2
+
γ
2
√
(1 −m)2 − (M1 −M2)2 − γ , (11)
with the constraints
− 1 ≤M1 ≤ 1; −1 ≤M2 ≤ 1
−(1 +m) ≤M1 +M2 ≤ 1 +m
−(1−m) ≤M1 −M2 ≤ 1−m . (12)
In the case of a quadratic replication rate, f0 = k1M
2
1 +
k2M
2
2 + k3M1M2, Eq. (11) becomes
lnZ
Nβ
= k1M
2
1 + k2M
2
2 + k3M1M2
+
γ
2
√
(1 +m)2 − (M1 +M2)2
+
γ
2
√
(1 −m)2 − (M1 −M2)2 − γ , (13)
with the constraints of Eq. (12).
As an example, we consider the replication rate func-
tion f0 = k(M
2
1 +M
2
2 +M1M2)/2. When m ≥ 0, and
the two peaks are within a Hamming distance of N/2 of
each other, there is a solution with M1 = M2 = M for
which
3kM2
2γ
+
[(
1 +m
2
)2
−M2
]1/2
− 1 +m
2
=
k
2γ
(〈u1〉2 + 〈u2〉2 + 〈u1〉〈u2〉) , (14)
where the observable, surface, magnetization is given by
〈ui〉 = 〈2Li/N − 1〉. We find
M1 =M2 =M =
√
(1 +m)2/4− γ2/(9k2) . (15)
We have for the mean replication rate, or fitness, per site
lnZ
βN
=
3k
2
(
1 +m
2
− γ
3k
)2
, (16)
so that [3]
〈u〉 = 1 +m
2
− γ
3k
. (17)
4m k 〈u1〉 〈u2〉 〈u1〉analytic 〈u2〉analytic
0.93 3.0 0.85 0.85 0.853 0.853
0.93 2.0 0.80 0.80 0.798 0.798
0.7 3.0 0.74 0.74 0.738 0.738
0.7 2.0 0.68 0.68 0.683 0.683
-0.7 3.0 0.52 -0.52 0.517 -0.517
-0.7 2.0 0.35 -0.35 0.35 -0.35
-0.93 3.0 0.63 -0.63 0.631 -0.631
-0.93 2.0 0.46 -0.46 0.465 -0.465
TABLE I: Comparison between the analytical formulas Eqs.
(17, 21) for the two peak landscape in the parallel model
and results from a direct numerical solution of the system of
differential equations, Eq. (5), for sequences of length N =
1000, with p(L1, L2, t = 0) = δ(L1, N)δ(L2, l).
When m < 0, and the two peaks are greater than a Ham-
ming distance of N/2 of each other, there is a solution
with M1 = −M2 =M for which
kM2
2γ
+
[
(
1−m
2
)2 −M2
]1/2
− 1−m
2
=
k
2γ
(〈u1〉2 + 〈u2〉2 + 〈u1〉〈u2〉) . (18)
One solution is
M1 = −M2 =
√
(1 −m)2/4− γ2/k2 , (19)
which gives for a mean replication rate, or fitness, per
site
lnZ
βN
=
k
2
(
1−m
2
− γ
k
)2
, (20)
so that [3]
〈u1〉 = −〈u2〉 = 1−m
2
− γ
k
. (21)
Numerical solution is in agreement with our analytical
formulas, as shown in Table I.
III. EIGEN MODEL WITH MULTIPLE PEAKS
A. Exact solution by a path integral representation
In the case of the Eigen model, the system is defined by
means of replication rate functions, rj , as well as degra-
dation rates, Dj :
dpi
dt
=
2N∑
j=1
[Qijrj − δijDj] pj − pi

 2N∑
j=1
(rj −Dj)pj

 .
(22)
Here the frequencies of a given genome, pi, satisfy∑2N
i=1 pi = 1. The transition rates are given by Qij =
qN−d(i,j)(1 − q)d(i,j), with the distance between two
genomes Si and Sj given by d(i, j) = (N−
∑N
n=1 s
i
ns
j
n)/2.
The parameter γ = N(1 − q) describes the efficiency of
mutations. We take γ = O(1). As in Eq. (6), we take
the replication and degradation rate to depend only on
the spin state, in particular on the distances from each
peak: ri = f(Si) and Di = D(Si) where
f(S) = Nf0(u1, . . . , uk), D(S) = Nd0(u1, . . . , uk) .
(23)
We find the path integral representation of the partition
function for the Eigen model for the K peak case in the
limit of long time as
Z =
∫
DMkDHkDm0Dh0 exp
{
N
∫ β
0
dβ′
[
f0(M1, . . . ,MK)e
−γ(1−m0) − h0m0
−
K∑
k=1
HkMk − d0(M1, . . . ,MK)
]
+N
2K∑
i=1
yi lnQ1
}
, (24)
where
Q1 = TrTˆ e
∫ β
0
dβ′
[
σxh0(β
′)+σz
∑K
k=1
αikHk(β
′)
]
. (25)
The Mk are the values of the magnetization, and γm0 is
an effective mutation rate. This form is derived in the
Appendix. Using that N is large, we take the saddle
point. As before, we find the mean excess replication
rate per site, fm = limt→∞
∑
i pi(t)(ri − Di)/N , from
the maximum of the expression for Z = Tr exp(−βH).
We find Z ∼ exp(βNfm), where
fm = f0(M1, . . . ,MK)e
−γ(1−
∑2K
i=1
yi
√
1−m2
i
)
−d0(M1, . . . ,MK) , (26)
and where m0,Mk are defined through the fields Hk:
Mk =
∑
i
yiαik
∑K
k′=1 αik′Hk′√
h20 + (
∑K
k′=1 αik′Hk′)
2
m0 =
∑
i
yi
h0√
h20 + (
∑K
k=1 αikHk)
2
. (27)
We define
mi =
∑K
k=1 αikHk√
h20 + (
∑K
k=1 αikHk)
2
. (28)
We thus find m0 =
∑2K
i=1 yi
√
1−m2i , giving Eq. (26).
5k/γ M 〈u〉 〈u〉analytic
1.2 0.24 0.065 0.068
1.4 0.31 0.112 0.113
1.6 0.35 0.146 0.147
1.8 0.38 0.172 0.172
2.0 0.41 0.192 0.193
TABLE II: Comparison between the analytical formulas Eqs.
(30) for the quadratic landscape (29) in the Eigen model and
results from a direct numerical solution of the system of dif-
ferential equations [7], for sequences of length N = 4000, with
p(u, t = 0) = δ(u, 1). We set γ = 5.
B. Eigen model with quadratic replication rate
without degradation
We apply our results to model qualitatively the inter-
action of a virus with a drug. In some situations, one
can describe the action of a drug against the virus sim-
ply as a one peak Eigen model: that is, replication rate
is a function of the Hamming distance from one peak.
The virus may increase its mutation rate, and at some
mutation rate there is an error catastrophe [16]. Let us
define the critical γ for the replication rate function
f0(M) = kM
2/2 + 1 . (29)
According to our analytical solution, Eq. (26), we con-
sider the maximum of the mean excess replication rate
per site expression
f0(M) exp[−γ(1−
√
1−M2)] . (30)
The error catastrophe occurs and leads to a phase with
M = 0 when k < γ. The error threshold for this
quadratic case is the same as in the case of the Crow-
Kimura model Eq. (1). Numerical solution is in agree-
ment with our analytical formulas, as shown in Table II.
C. Simple formulas for two peak case
In the two peak, K = 2, case we can define the mi
from Eq. (28) from the system
M1 =
1 +m
2
(m1 +m2) +
1−m
2
(m1 −m2)
M2 =
1 +m
2
(m1 +m2)− 1−m
2
(m1 −m2) , (31)
where we have definedm1,m2 in terms of themi from Eq.
(28) by m++ = −m−− = m1+m2 and m+− = −m−+ =
m1 −m2 , We have for the mean excess replication rate
per site
fm = f0(M1,M2) exp
[
− γ
(
1
−1 +m
2
√
1− (M1 +M2)2/(1 +m)2
−1−m
2
√
1− (M1 −M2)2/(1−m)2
)]
−d0(M1,M2) . (32)
IV. BIOLOGICAL APPLICATIONS
The Eigen model is commonly used to consider virus
or cancer evolution. We here consider an evolving virus
or cancer and its control by a drug or the immune sys-
tem, using the K = 2, two-peak version of the Eigen
model. To model this situation, we consider there to
be an optimal genome for virus replication, and we con-
sider the replication rate function f0(M1,M2) to depend
only on the Hamming distance of the virus or cancer
from this preferred genome, N(1 −M1)/2. Conversely,
there is another point in genome space that the drug or
immune suppresses most strongly, and we consider the
degradation rate function d0(M1,M2) to depend only on
the Hamming distance from this point, N(1 − M2)/2.
While each of the functions f0 and d0 depend only on
one of the two distances, this is multiple-peak problem,
because both distances are needed to describe the evolu-
tion of the system.
A. Interaction of virus with a drug
We first consider a virus interacting with a drug. We
model this situation by the Eigen model with one peak in
the replication rate function and one peak in the degra-
dation rate function. The virus replicates most quickly
at one point in genome space, with the rate at all other
points given by a function that depends on the Hamming
distance from this one point. That is, in Eq. (32) we have
f0(M1,M2) =


A, M1 = 1
1, M1 < 1
. (33)
At another point in genome space, a drug suppresses the
virus most strongly. We consider the case of exponen-
tial degradation, a generic and prototypical example of
recognition [13]:
d0(M1,M2) = e
−b(1−M2) . (34)
Applying the multiple-peak formalism, we find two
phases. There is a selected, ferromagnetic (FM) phase
with M1 = 1, M2 = m and mean excess replication rate
per site
fm = Ae
−γ − exp(−b(1−m)) . (35)
There is also a non-selective NS phase, with M1 < 1.
The values of M1 and M2 in the NS phase are those
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FIG. 1: A phase diagram for the interaction of virus and
drug, according to the narrow replication advantage model,
Eqs. (34) and (33). We set b = 3.5 in the exponential degra-
dation function Eq. (34), and γ = 1. As the point in genome
space at which the drug is most effective moves toward the
point in genome space at which the virus grows most rapidly,
m → 1, a higher replication rate of the virus is required for
the virus to survive. In the NS phase, the drug eliminates the
virus. In inset is shown the phase diagram for the interac-
tion of an adaptable virus and a drug, according to the flat
peak replication advantage model, Eqs. (34) and (36). We use
M0 = 0.9 to represent a broad peak for the virus replication
rate.
which maximize Eq. 32 given the constraints of Eq. (12).
The error threshold corresponds to the situation when
the mean excess replication rate of the FM and NS phases
are equal. The phase diagram as a function of the opti-
mal replication rate of the virus and the distance between
the points of optimal virus growth and optimal virus sup-
pression is shown in Fig. 1. The optimal replication rate
is A, and the distance between the points of optimal virus
growth and optimal virus suppression is N − l, where the
parameter m is defined as m = (2l − N)/N . As the
point in genome space at which the drug is most effec-
tive moves toward the point in genome space at which
the virus grows most rapidly, the virus is more read-
ily eradicated. Alternatively, one can say that as the
point in genome space at which the drug is most effec-
tive moves toward the point in genome space at which
the virus grows most rapidly, a higher replication rate of
the virus is required for its survival.
B. Interaction of an adaptable virus with a drug
We now consider a virus that replicates with rate A
when the genome is within a given Hamming distance
from the optimal genome and with rate 1 otherwise. That
is, in Eq. (32) we have
f0(M1,M2) =


A, M0 ≤M1 ≤ 1
1, −1 ≤M1 < M0
, (36)
where M0 > 0 and close to one. We suppression of the
virus by the drug as expressed in Eq. (34).
There is again a ferromagnetic (FM) phase with a suc-
cessful selection. In the FM phase, one has M0 ≤ M1 ≤
1. The evolved values of M1 and M2 maximize
fm = A exp
[
− γ
(
1
−1 +m
2
√
1− (M1 +M2)2/(1 +m)2
−1−m
2
√
1− (M1 −M2)2/(1−m)2
)]
−d0(M1,M2) . (37)
There is also a NS phase where the virus has been driven
off its advantaged peak,M1 < M0. In this case, one seeks
a maximum of Eq. (32) with f0 = 1 via M1 and M2 in
the range −1 ≤ M1 ≤ M0, −1 ≤ M2 ≤ 1, subject to the
constraints of Eq. (12).
A phase diagram for this case is shown in the inset
to Fig. 1. The broader range of the virus fitness land-
scape allows the virus to survive under a greater drug
pressure in model Eq. (36) versus Eq. (33). That is, as
the point in genome space at which the drug is most ef-
fective moves toward the point in genome space at which
the virus grows most rapidly, the adaptable virus is still
able to persist due to the greater range of genotype space
available in the FM phase. For such an adaptable virus, a
more specific, multi-drug cocktail might be required for
eradication. A multi-drug cocktail provides more sup-
pression in a broader range of genome space, so that the
adaptable drug may be eradicated under a broader range
of conditions.
C. Original antigenic sin
The immune system acts much like a drug, as a nat-
ural protection against death by infection. Prior expo-
sure such as vaccination typically increases the immune
control of a virus. In some cases, the immune control
of a virus is non-monotonic in the distance between the
vaccine and the virus [13]. This phenomenon is termed
original antigenic sin. To model original antigenic sin,
we consider a non-monotonic degradation function, cen-
tered around the second peak, which represents the non-
monotonic behavior of the binding constant, as in our
previous model [13]. We fit the binding constant data [13]
to a sixth order polynomial in p, where p = (1−M2)/2 is
the relative distance between the recognition of the anti-
body and the virus. The degradation function is shown
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FIG. 2: A phase diagram corresponding to the original anti-
genic sin model is shown. The degradation function (shown
in inset) is chosen to closely reproduce the binding con-
stant behavior in [13], with a limiting degradation rate of
d0(M1,M2 = −1) = 1. We use γ = 1. The virus replication
advantage required to escape immune system control is a non-
monotonic function of the Hamming distance, N(m − 1)/2,
between the point in genome space at which the immune sys-
tem is most effective and the point in genome space at which
the virus grows most rapidly.
in inset in Fig. 2. We consider a single peak virus repli-
cation rate, Eq. (33).
There is an interesting phase structure as a function
of m. From Eq. (32), we have a FM phase with M1 = 1,
M2 = m. We also have a non-selective NS phase, with
M1 < 1, where M1,M2 are determined by maximization
of Eq. (32) with f0 = 1 under the constraints of Eq. (12).
The phase diagram for typical parameters [13], is shown
in Fig. 2. A continuous phase boundary is observed be-
tween the FM and NS phases. The virus replication rate
required to escape eradication by the adaptive immune
system depends on how similar the virus and the vaccine
are. When the vaccine is similar to the virus, m near 1,
a large virus replication rate is required to escape erad-
ication. This result indicates the typical usefulness of
vaccines in protection against and eradication of viruses.
When the vaccine is not similar to the virus, m < 0, the
vaccine is not effective, and only a typical virus replica-
tion rate is required.
When the vaccine is somewhat similar to, but not iden-
tical to, the virus, the replication rate required for virus
survival is non-monotonic. This result is due to the non-
monotonic degradation rate around the vaccine degrada-
tion peak. The minimum in the required virus replica-
tion rate, m ≈ 0.30, corresponds to the minimum in the
degradation rate, M2 ≈ 0.30. The competition between
the immune system, vaccine, and virus results in a non-
trivial phase transition for the eradication of the virus.
D. Tumor control and proliferation
We consider cancer to be a mutating, replicating ob-
ject, with a flat replication rate around the first peak,
Eq. (36) and Eq. (32). We consider the immune sys-
tem to be able to eradicate the cancer when the cancer
is sufficiently different from self. Thus, the T cells have
a constant degradation rate everywhere except near the
self, represented by the second peak:
d0(M1,M2) =


B, −1 ≤M2 < Mb
0, Mb ≤M2 ≤ 1
. (38)
To be consistent with the biology, we assumeMb > 0. We
also assume M0 > 1/2. Typically, also, the Hamming
distance between the cancer and the self will be small,
m will be positive and near unity, although we do not
assume this.
There are four possible selective, ferromagnetic phases.
We find the phase boundaries analytically, as a function
of m = (2l − N)/N . For mM0 < Mb, there is a FM4
phase with M1 = M0 and M2 = mM0. The mean ex-
cess replication rate per site is fm = Ae
γ(
√
1−M20−1)−B.
There is a FM3 phase with M1 = M0 and M2 = Mb.
The mean excess replication rate per site is fm =
Aeγ(
√
(1+m)2−(M0+Mb)2+
√
(1−m)2−(M0−Mb)2−2)/2. This
phase is chosen over the FM4 phase when the mean ex-
cess replication rate is greater. For mM0 ≥ Mb there is
a FM2 phase with M1 =M0 and M2 = mM0. The mean
excess replication rate per site is fm = Ae
γ(
√
1−M20−1).
For mMb ≥ M0 there is a FM1 phase with M1 = mMb
and M2 =Mb. The mean excess replication rate per site
is fm = Ae
γ(
√
1−M2
b
−1).
There are two non-selective phases. There is a NS1
phase with M1 = mMb and M2 =Mb. The mean excess
replication rate per site is fm = e
γ(
√
1−M2
b
−1). There
is a NS2 phase with M1 = M2 = 0. The mean excess
replication rate per site is fm = 1−B.
In Fig. 3 is shown the phase diagram for cancer pro-
liferation. According to our previous model [13, 17], we
choose (1 −Mb)/2 = 0.23. We choose M0 = 0.9 for the
width of the advantaged cancer phase. We choose the im-
mune suppression rate as B = 1. As the cancer becomes
more similar to the self, the immune control becomes less
effective, and the replication rate required for the cancer
to proliferate becomes less. Three of the four selective
and one of the two non-selective phases are present for
this set of parameters.
V. DISCUSSION AND CONCLUSION
We have used the Eigen model to consider the inter-
action of a virus or cancer with a drug or the immune
system. One can also use the parallel model to represent
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FIG. 3: A phase diagram corresponding to the immune con-
trol of cancer is shown. We use γ = 1, B = 1, M0 = 0.9,
and Mb = 0.54. The cancer replication advantage required
to escape immune system control decreases as the Hamming
distance between the cancer and the self decreases, m → 1.
Three of the four selective and one of the two non-selective
phases are present for the chosen parameters.
the replication dynamics of the virus or the cancer. This
would be an interesting application of our formalism.
Another application of the formalism would be to con-
sider explicitly the degradation induced by multi-drug
cocktails. That is, one would consider one peak to repre-
sent the preferred virus genome and K − 1 degradation
peaks to represent the K − 1 drugs. We note that in the
general case, the yi parameters depend on the explicit
location of the drug degradation peaks, not simply the
distance between them. Results from this application of
the formalism could be quite illuminating as regards the
evolution of multi-drug resistance.
In conclusion, we have solved two common evolution
models with general fitness, or replication and degrada-
tion rate, landscapes that depend on the Hamming dis-
tances from several fitness peaks. Why is this important?
First, we have solved the microscopic models, rather than
assuming a phenomenological macroscopic model. As
is known in statistical mechanics, a phenomenological
model may not always detect the fine structure of criti-
cal phenomena. Second, approximate or numerical solu-
tions, while useful, do not always explicitly demonstrate
the essence of the phenomenon. With analytical solu-
tions, the essence of phenomenon is transparent. Third,
we have derived the first path integral formulation of the
Eigen model. This formulation may prove useful in other
studies of this model of molecular evolution.
Our results for cancer are a case in point. There are
four stable selective phases and two stable non-selective
phases. These results may help to shed light on the,
at present, poorly understood phenomena of interaction
with the immune system, and on why the immune re-
sponse to cancer and to viruses differs in important ways.
These phases could well also be related to the differ-
ent stages, or grades, through which tumors typically
progress.
Our results are a first step toward making the connec-
tion with evolution on rugged fitness landscapes, land-
scapes widely accepted to be accurate depictions of na-
ture. We have applied our solution of these microscopic
complex adaptive systems to model four situations in bi-
ology: how a virus interacts with drug, how an adapt-
able virus interacts with a drug, the problem of original
antigenic sin [13], and immune system control of a pro-
liferating cancer.
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Appendix
In this section, we derive the path integral represen-
tation for the solution to the Eigen model. For simplic-
ity, we show the derivation for the K = 1 case. To our
knowledge, this is the first path integral expression rep-
resentation of the solution to the Eigen model. This path
integral representation allows us to make strong analytic
progress. We start from the quantum representation of
the Eigen model [4, 10]. The Hamiltonian is given by
−H =
N∑
l=0
Ne−γ
( γ
N
)l ∑
1≤i1<i2<...<il≤N
σxi1σ
x
i2 . . . σ
x
il
×f0(σz)−Nd0(σz)
≈ Ne−γe(γ/N)
∑
i
σxi f0(σ
z)−Nd0(σz) , (39)
where we have used the fact that with γ/N small, we
need to consider only l ≪ N spin flips. The partition
function is decomposed by a Trotter factorization:
Z = Tre−βH
= Tr〈S1|e−βH/L|S2〉〈S2|e−βH/L|S3〉 . . .
×〈SL|e−βH/L|S1〉 . (40)
Here
〈Sl−1|e−βH/L|Sl〉
= 〈Sl−1|e
(βN/L)
[
e−γe
(γ/N)
∑
i
σx
i f0(σ
z)−d0(σ
z)
]
|Sl〉
= 〈Sl−1|I + βN
L
[
e−γe(γ/N)
∑
i
σxi f0(
∑
n
sln/N)
−d0(
∑
n
sln/N)
]
|Sl〉 . (41)
9We use the notation Ml =
∑
n s
l
n/N . We find
αl = 〈Sl−1|I + βN
L
e−γf0(
∑
n
sln/N)e
(γ/N)
∑
i
σxi
−βN
L
d0(
∑
n
sln/N)|Sl〉
= 〈Sl−1|Sl〉
[
1− βN
L
d0(Ml)
]
+
βNe−γ
L
f0(Ml)e
B
∑
n
(sl−1n s
l
n−1) , (42)
where e−2B = γ/N . We thus find
αl = ∆(dl)
[
1− βN
L
d0(Ml)
]
+
βN
L
e−γf0(Ml)e
Bdl ,(43)
where dl =
∑
n(s
l−1
n s
l
n − 1). To represent this in path
integral form, we consider
1
(2π)2
∫
dhdmdψe∆tNe
−γf0(Ml)e
Bme−ψm−∆tNd0(Ml)
×eψd−h(m−d)
=
1
2π
∫
dhdm
[
δ(d)e−∆tNd0(Ml) +∆tNe−γf0(Ml)
×eBmδ(m− d)
]
e−h(m−d) +O[(∆t)2]
=
∫
dm
[
δ(d)δ(m − d)e−∆tNd0(Ml) +∆tNe−γf0(Ml)
×eBmδ(m− d)δ(m− d)
]
= δ(d)e−∆tNd0(Ml) +∆tNe−γf0(Ml)e
Bdδ(0)
= δ(0)
[
∆(d)e−∆tNd0(Ml) +∆tNe−γf0(Ml)e
Bd
]
,(44)
where ∆t = β/L. We note that, had we used a Fourier
representation of the delta function on the finite domain
[−A/2, A/2], instead of the infinite domain (−∞,∞),
the expression 2πδ(0) simply becomes A; moreover such
a finite representation of the delta function is a suffi-
ciently accurate representation of the ∆(dl) constraint
when A ≫ N . Ignoring the constant prefactor δ(0)
terms, we can write the full partition function as
Z = Tr
∫
DψDhDm
×e(βN/L)
∑
l
[e−γf0(Ml)eBmle−ψlml−d0(Ml)]
×e
∑
l
ψldl+(βN/L)
∑
l
[−hlml+hldl] . (45)
We now introduce the integral representation of the con-
straint δ[(β/L)(NMl −
∑
n s
l
n)]. After rescaling Bml →
ml, hl → Bhl we find
Z = Tr
∫
DψDhDmDHDMe(βN/L)
∑
l
[e−γf0(Ml)e
ml
×ee−ψlml/B−d0(Ml)−hlml−HlMl]
×e(β/L)
∑
l
Hl
∑
n
sln+
∑
l
(ψl+βNBhl/L)
∑
n
(sl−1n s
l
n−1) .
(46)
We note by an expansion of the
exp[(βN/L)e−γf0(Ml)e
ml exp(−ψlml/B)] =∑∞
kl=0
[(βN/L)e−γf0(Ml)e
ml ]kl exp(−klψlml/B)/kl!
term in Eq. (46) to first order in βN/L that the integral
over ψl gives nothing more than δ(−klml/B + dl) for
kl = 0, 1. This condition, however, is already enforced by
the hl field when kl = 1 and by the ml field when kl = 0
if we take as a rule to disallow mutations when hl = 0.
We can, thus, remove the integral over ψ, removing the
δ(0) that we anticipated, to find
Z =
∫
DhDmDHDMe(βN/L)
∑
l
[e−γf0(Ml)e
ml−d0(Ml)
×e−hlml−HlMl]Q , (47)
where
Q = Tre(β/L)
∑
l
Hl
∑
n
sln+(βNB/L)
∑
l
hl
∑
n
(sl−1n s
l
n−1)F
.(48)
Here Q is the partition function of N 1-d Ising
models of length L. Here F enforces the con-
straint of disallowing mutations when hl = 0: F =∏L
l=1∆{∆(hl)[
∑
n(s
l−1
n s
l
n−1)]}. We note that Q = QN1 ,
where Q1 is the partition function of one of these models.
We are not, at this point, allowed to assume that the Hl
or hl fields are constant over l. Indeed, by Taylor series
expanding the first term in Eq. 47 and integrating over
ml, we find that hl = 0 or hl = L/(βN). For hl = 0,
we disallow mutations, as formalized by F . Thus, we can
replace e−2B by γtl/N , where tl = 0 if hl = 0, and tl = 1
if hl = L/(βN). We evaluate the partition function Q1
with an ordered product of transfer matrices. To first or-
der in β/L the matrix at position l is given by Tl = I+ ǫl
where
ǫl =
(
βHl
L
γtl
N
γtl
N −βHlL
)
=
(
βHl
L
βγhl
L
βγhl
L −βHlL
)
. (49)
We find
Q1 = Tr
∏
l
Tl
∼ Tr
∏
l
eǫl . (50)
We rescale h→ h/γ and m→ mγ and take the continu-
ous limit to find
Q1 = TrTˆ e
∫ β
0
dβ′[σzH(β′)+σxh(β′)]
, (51)
where the operator Tˆ indicates (reverse) time ordering,
and β′ = β(L − l)/L. We find the form of the partition
function to be
Z =
∫
DhDmDHDM
10
e
N
∫
β
0
dβ′[e−γf0(M)e
γm−d0(M)−hm−HM ]+N lnQ1 .
(52)
Noting the N prefacing the entire term in
the exponential, we take the saddle point.
We note that δQ1/δH(β
′)|H(β′)=H,h(β′)=h =
(βH/
√
H2 + h2)2 sinh(β
√
H2 + h2) and
δQ1/δh(β
′)|H(β′)=H,h(β′)=h =
(βh/
√
H2 + h2)2 sinh(β
√
H2 + h2). We, thus, find
a solution of the saddle point condition to be fields
H,M, h,m independent of β that maximize
lnZ
N
= β
[
f0(M)e
−γeγm − d0(M)− hm−HM ]
+ ln[2 cosh(β
√
H2 + h2)
]
, (53)
when the fields are averaged over a range ∆β = O(1/N)
by the saddle point limit. In the limit of large β, we find
lnZ
βN
= max
M,H,m,h
[
f0(M)e
−γeγm − d0(M)− hm−HM
+(H2 + h2)1/2
]
. (54)
One can also derive Eq. (54) by means of a series expan-
sion in β, a “high temperature” expansion.
The generalization of the path integral representation
to the multiple-peak Eigen case proceeds as in the parallel
case. One introduces K fields for the magnetizations,
Mk, and K fields enforcing the constraint, Hk. One
also finds in the linear field part of the Ising model the
sum
∑K
k=1H
k
l
∑
n v
k
ns
l
n instead of simply Hl
∑
n s
l
n. The
definition of the yi and the αik allows one to rewrite this
in the form that leads to Eq. (7) or (24).
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